Journal article
Borderline Resectable Pancreatic Cancer
Indian journal of surgical oncology, Vol.6(1), pp.63-68
01/04/2015
DOI: 10.1007/s13193-014-0374-8
PMCID: PMC4412859
PMID: 25937766
Abstract
Borderline resectable pancreatic cancer (BRPC) is an evolving diagnostic entity that blurs the distinction between resectable and locally advanced pancreatic cancer (Varadhachary et al. Ann Surg Oncol 13:1035–1046,
2006
). Until recently the management of this disease has been poorly defined; however, consensus guidelines have been developed regarding the proper management of this diagnostic entity. Recent studies have shown that if appropriately identified and treated, this subset of disease can have outcomes similar to pancreatic cancer that is defined as resectable (Laurence et al. J Gastrointest Surg 15:2059–2069,
2011
). The aim of this review is to outline the current consensus on definitions, workup and management of BRPC, and also provide a summary of issues that require progress as defined by the International Study Group of Pancreatic Surgery (ISGPS).
Details
- Title: Subtitle
- Borderline Resectable Pancreatic Cancer
- Creators
- Bhargava Mullapudi - University of Nebraska Medical CenterPatrick J. Hawkes - University of Nebraska Medical CenterAsish Patel - University of Nebraska Medical CenterChandrakanth Are - University of Nebraska Medical CenterSubhasis Misra - Texas Tech University Health Sciences Center
- Resource Type
- Journal article
- Publication Details
- Indian journal of surgical oncology, Vol.6(1), pp.63-68
- DOI
- 10.1007/s13193-014-0374-8
- PMID
- 25937766
- PMCID
- PMC4412859
- NLM abbreviation
- Indian J Surg Oncol
- ISSN
- 0975-7651
- eISSN
- 0976-6952
- Publisher
- Springer India
- Language
- English
- Date published
- 01/04/2015
- Academic Unit
- Surgery
- Record Identifier
- 9984322800202771
Metrics
17 Record Views